MX2017005578A - Métodos de administración de composiciones de amantadina. - Google Patents
Métodos de administración de composiciones de amantadina.Info
- Publication number
- MX2017005578A MX2017005578A MX2017005578A MX2017005578A MX2017005578A MX 2017005578 A MX2017005578 A MX 2017005578A MX 2017005578 A MX2017005578 A MX 2017005578A MX 2017005578 A MX2017005578 A MX 2017005578A MX 2017005578 A MX2017005578 A MX 2017005578A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- administering amantadine
- compositions
- amantadine compositions
- administering
- Prior art date
Links
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003805 amantadine Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000016285 Movement disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describen los métodos de administración de amantadina para mejorar los trastornos de movimiento, así como las composiciones adecuadas para ello.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462075137P | 2014-11-04 | 2014-11-04 | |
PCT/US2015/058872 WO2016073510A1 (en) | 2014-11-04 | 2015-11-03 | Methods of administering amantadine compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017005578A true MX2017005578A (es) | 2018-01-11 |
Family
ID=55909712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017005578A MX2017005578A (es) | 2014-11-04 | 2015-11-03 | Métodos de administración de composiciones de amantadina. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20160228388A1 (es) |
EP (2) | EP3215132B1 (es) |
JP (1) | JP6735020B2 (es) |
CN (1) | CN107205950B (es) |
AU (1) | AU2015343199B2 (es) |
BR (1) | BR112017009289A2 (es) |
CA (1) | CA2966195C (es) |
ES (1) | ES2865278T3 (es) |
HU (1) | HUE055779T2 (es) |
MX (1) | MX2017005578A (es) |
PL (1) | PL3215132T3 (es) |
PT (1) | PT3215132T (es) |
SI (1) | SI3215132T1 (es) |
WO (1) | WO2016073510A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10154971B2 (en) | 2013-06-17 | 2018-12-18 | Adamas Pharma, Llc | Methods of administering amantadine |
WO2019040748A1 (en) | 2017-08-24 | 2019-02-28 | Adamas Pharma, Llc | AMANTADINE COMPOSITIONS, THEIR PREPARATION, AND METHODS OF USE |
TR201720406A2 (tr) | 2017-12-14 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Bi̇r i̇skelet kasi gevşeti̇ci̇si̇ ve bi̇r multi̇pl skleroz tedavi̇ edi̇ci̇ ajan i̇çeren kombi̇nasyonlar |
EP3810110A4 (en) | 2018-06-21 | 2022-03-16 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | COMBINATION OF FINGOLIMOD AND AMANTADINE |
TR201818307A2 (tr) * | 2018-11-30 | 2020-06-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Di̇meti̇l fumarat i̇çeren bi̇r kompozi̇syon |
TR201818859A2 (tr) | 2018-12-07 | 2020-06-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Di̇meti̇l fumarat ve en az bi̇r kas gevşeti̇ci̇ ajan i̇çeren bi̇r kombi̇nasyon |
TR201819202A2 (tr) | 2018-12-12 | 2020-06-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Bi̇r multi̇pl skleroz ajani ve en az bi̇r kas relaksan ajan i̇çeren bi̇r kombi̇nasyon |
TR201820976A2 (tr) | 2018-12-28 | 2020-07-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Fi̇ngoli̇mod ve bi̇r spazmoli̇ti̇k i̇çeren farmasöti̇k kombi̇nasyonlar |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5221536A (en) | 1990-05-07 | 1993-06-22 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
US5358721A (en) | 1992-12-04 | 1994-10-25 | Alza Corporation | Antiviral therapy |
AUPN605795A0 (en) | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
WO2006053067A2 (en) * | 2004-11-09 | 2006-05-18 | Prestwick Pharmaceuticals, Inc. | Combination of amantadine and a tetrabenazine compound for treating hyperkinetic disorders |
US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
CA2588296A1 (en) | 2004-11-24 | 2006-06-01 | Neuromolecular Pharmaceuticals, Inc. | Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease |
US8574626B2 (en) | 2004-12-03 | 2013-11-05 | Osmotica Kereskedelmi és Szolgáltató KFT | Osmotic device containing amantadine and an osmotic salt |
US20080279819A1 (en) * | 2005-02-15 | 2008-11-13 | Adamas Pharmaceuticals, Inc. | Combinations Therapy for Treatment of Demyelinating Conditions |
RU2007140348A (ru) | 2005-04-06 | 2009-05-20 | Адамас Фармасьютикалс, Инк. (Us) | Способы и композиции для лечения заболеваний цнс |
US7981930B2 (en) | 2007-03-13 | 2011-07-19 | Adamas Pharmaceuticals, Inc. | Compositions and kits for treating influenza |
CA2994873A1 (en) | 2009-12-02 | 2011-06-09 | Adamas Pharmaceuticals, Inc. | Amantadine compositions and methods of use |
WO2014093475A1 (en) * | 2012-12-11 | 2014-06-19 | Acorda Therapeutics, Inc. | Methods for treating parkinson's disease using aminopyridines |
US10154971B2 (en) * | 2013-06-17 | 2018-12-18 | Adamas Pharma, Llc | Methods of administering amantadine |
-
2015
- 2015-11-03 JP JP2017522637A patent/JP6735020B2/ja active Active
- 2015-11-03 EP EP15857591.0A patent/EP3215132B1/en active Active
- 2015-11-03 HU HUE15857591A patent/HUE055779T2/hu unknown
- 2015-11-03 CA CA2966195A patent/CA2966195C/en active Active
- 2015-11-03 EP EP21153566.1A patent/EP3909569A1/en not_active Withdrawn
- 2015-11-03 WO PCT/US2015/058872 patent/WO2016073510A1/en active Application Filing
- 2015-11-03 PT PT158575910T patent/PT3215132T/pt unknown
- 2015-11-03 ES ES15857591T patent/ES2865278T3/es active Active
- 2015-11-03 MX MX2017005578A patent/MX2017005578A/es active IP Right Grant
- 2015-11-03 CN CN201580072014.7A patent/CN107205950B/zh active Active
- 2015-11-03 PL PL15857591T patent/PL3215132T3/pl unknown
- 2015-11-03 US US14/931,546 patent/US20160228388A1/en not_active Abandoned
- 2015-11-03 AU AU2015343199A patent/AU2015343199B2/en active Active
- 2015-11-03 SI SI201531585T patent/SI3215132T1/sl unknown
- 2015-11-03 BR BR112017009289A patent/BR112017009289A2/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20160228388A1 (en) | 2016-08-11 |
CN107205950A (zh) | 2017-09-26 |
CA2966195A1 (en) | 2016-05-12 |
JP2017533211A (ja) | 2017-11-09 |
WO2016073510A1 (en) | 2016-05-12 |
EP3215132B1 (en) | 2021-01-27 |
PT3215132T (pt) | 2021-05-07 |
CN107205950B (zh) | 2021-06-04 |
EP3909569A1 (en) | 2021-11-17 |
EP3215132A4 (en) | 2018-07-11 |
AU2015343199B2 (en) | 2021-04-08 |
HUE055779T2 (hu) | 2021-12-28 |
SI3215132T1 (sl) | 2021-11-30 |
AU2015343199A1 (en) | 2017-05-18 |
EP3215132A1 (en) | 2017-09-13 |
ES2865278T3 (es) | 2021-10-15 |
CA2966195C (en) | 2024-04-30 |
BR112017009289A2 (pt) | 2017-12-19 |
JP6735020B2 (ja) | 2020-08-05 |
PL3215132T3 (pl) | 2021-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023008686A (es) | Polinucleotidos moduladores. | |
PH12016501966A1 (en) | Compounds and compositions as toll-like receptor 7 agonists | |
MX2021014128A (es) | Polimorfos de selinexor. | |
MX2017005578A (es) | Métodos de administración de composiciones de amantadina. | |
PH12016501151A1 (en) | Nrf2 regulators | |
MD20150091A2 (ro) | Compuşi antivirali | |
JO3466B1 (ar) | مواد ضابطة لتترا هيدرو بيريدوبيرازينات من gpr6 | |
MX2017008444A (es) | Picolinamidas como fungicidas. | |
TW201613853A (en) | Synthesis of polycyclic-carbamoylpyridone compounds | |
EP3102554A4 (en) | Conversion of 2,3-butanediol to butadiene | |
PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
MX345926B (es) | Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas. | |
AU2018253600A1 (en) | Dosage forms and therapeutic uses of l-4-chlorokynurenine | |
AU2018253594A1 (en) | Dihydroxyphenyl neurotransmitter compounds, compositions and methods | |
MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
IN2014CH00840A (es) | ||
IN2014CH00151A (es) | ||
IN2013MU01113A (es) | ||
MX2016012758A (es) | Composicion hiperosmolar de acido hialuronico. | |
IN2014CH00304A (es) | ||
MX2015016603A (es) | Composiciones de corticosteroides. | |
EA201691465A1 (ru) | Средство для лечения сердечно-сосудистых заболеваний | |
IN2013CH04314A (es) | ||
PH12017501147A1 (en) | Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs | |
IN2013MU03768A (es) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
PD | Change of proprietorship |
Owner name: ADAMAS PHARMA, LLC |